SymBiosis Capital Partners »

Rani Therapeutics Hldgs shares owned by SymBiosis Capital Partners

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by SymBiosis Capital Partners from 13F filings

Historical chart of SymBiosis Capital Partners investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by SymBiosis Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by SymBiosis Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 3.7M 0.73

More positions owned by SymBiosis Capital Partners

Evommune Com Shs (EVMN)
Inventiva Ads (IVA)
Wave Life Sciences SHS (WVE)
Rani Therapeutics Holdings Com Cl A (RANI)
Clene Nanomedicine Com New (CLNN)
Surrozen *w Exp 08/01/203 (SRZNW)

View all positions for SymBiosis Capital Partners

Top funds holding Rani Therapeutics Hldgs

RA Capital Management
Samsara BioCapital
AWM Investment Company
Vanguard Group
Vanguard Capital Management
SymBiosis Capital Partners
Longaeva Partners
Siren
Susquehanna International
Geode Capital Management
BlackRock
Nan Fung Group Holdings
683 Capital Management
Vanguard Fiduciary Trust
Millennium Management

View all funds holding Rani Therapeutics Hldgs